ADUMED ApS: Financial statements 2025
CVR: 41975989
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
ADUMED ApS (CVR 41975989) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 2 compared with DKK -485 the year before. Equity in the 2025 report amounted to DKK 596,217. The solvency ratio was 64.6%.
- Profit/Loss
- DKK 2
- Equity
- DKK 596,217
- Total Assets
- DKK 922,969
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 2 | 596 t. | - |
| 2024 | - | -530 | -485 | -364 t. | 0 |
| 2023 | - | -48 t. | -138 t. | -363 t. | - |
| 2022 | - | -46 t. | -265 t. | -225 t. | - |
Official annual report
How creditworthy is ADUMED ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 30, 2025, Jeannette Buchard Denker is registered as adm. dir. of ADUMED ApS.
As of June 30, 2025, Lars Buchard Denker has stepped down as adm. dir. of ADUMED ApS.
As of June 30, 2025, Sandvig Capital ApS is registered as an owner of ADUMED ApS with an ownership share of 100%.
About ADUMED ApS
ADUMED ApS is a Danish company of the type Anpartsselskab based in Aabenraa, founded in 2020. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Jeannette Buchard Denker. The company is owned by Sandvig Capital ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 2 compared with DKK -485 the year before. Equity in the 2025 report amounted to DKK 596,217.